Literature DB >> 7986010

In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.

G Klopman1, J Y Li, S Wang, A J Pearson, K Chang, M R Jacobs, S Bajaksouzian, J J Ellner.   

Abstract

The relationship between the structures of quinolones and their anti-Mycobacterium avium activities has been previously derived by using the Multiple Computer-Automated Structure Evaluation program. A number of substructural constraints required to overcome the resistance of most of the strains have been identified. Nineteen new quinolones which qualify under these substructural requirements were identified by the program and subsequently tested. The results show that the substructural attributes identified by the program produced a successful a priori prediction of the anti-M. avium activities of the new quinolones. All 19 quinolones were found to be active, and 4 of them are as active or better than ciprofloxacin. With these new quinolones, the updated multiple computer-automated structure evaluation program structure-activity relationship analysis has helped to uncover additional information about the nature of the substituents at the C5 and C7 positions needed for optimal inhibitory activity. A possible explanation of drug resistance based on the observation of suicide inactivation of bacterial cytochrome P-450 by the cyclopropylamine moiety has also been proposed and is discussed in this report. Furthermore, we confirm the view that the amount of the uncharged form present in a neutral pH solution plays a crucial role in the drug's penetration ability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986010      PMCID: PMC284638          DOI: 10.1128/AAC.38.8.1794

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Oxidation of cycloalkylamines by cytochrome P-450. Mechanism-based inactivation, adduct formation, ring expansion, and nitrone formation.

Authors:  A Bondon; T L Macdonald; T M Harris; F P Guengerich
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

Review 3.  P450 genes: structure, evolution, and regulation.

Authors:  D W Nebert; F J Gonzalez
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 4.  Inhibitors of DNA topoisomerases.

Authors:  K Drlica; R J Franco
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

Review 5.  Inactivation of cytochrome P-450 and monoamine oxidase by cyclopropylamines.

Authors:  R H Tullman; R P Hanzlik
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

6.  New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.

Authors:  J M Domagala; L D Hanna; C L Heifetz; M P Hutt; T F Mich; J P Sanchez; M Solomon
Journal:  J Med Chem       Date:  1986-03       Impact factor: 7.446

7.  Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.

Authors:  G Klopman; S Wang; M R Jacobs; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.

Authors:  C R Horsburgh; D L Cohn; R B Roberts; H Masur; R A Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

9.  Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.

Authors:  D M Yajko; P S Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

10.  1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.

Authors:  J M Domagala; C L Heifetz; M P Hutt; T F Mich; J B Nichols; M Solomon; D F Worth
Journal:  J Med Chem       Date:  1988-05       Impact factor: 7.446

View more
  8 in total

1.  Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.

Authors:  R Gozalbes; M Brun-Pascaud; R García-Domenech; J Gálvez; P M Girard; J P Doucet; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.

Authors:  J D Vrany; P S Stewart; P A Suci
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

3.  N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.

Authors:  G Klopman; D Fercu; T E Renau; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies.

Authors:  Deepti Mathpal; Mukesh Masand; Anisha Thomas; Irfan Ahmad; Mohd Saeed; Gaffar Sarwar Zaman; Mehnaz Kamal; Talha Jawaid; Pramod K Sharma; Madan M Gupta; Santosh Kumar; Swayam Prakash Srivastava; Vishal M Balaramnavar
Journal:  RSC Adv       Date:  2021-10-25       Impact factor: 4.036

5.  A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors:  P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 6.  Activity of quinolones against mycobacteria.

Authors:  M R Jacobs
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis.

Authors:  P S Skinner; S K Furney; D A Kleinert; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

8.  Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.

Authors:  Alexandra Aubry; Xiao-Su Pan; L Mark Fisher; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.